Regulation of adult pancreatic beta cell replication

成人胰腺β细胞复制的调节

• 批准号: 8398946
• 负责人: Maureen A Gannon
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8398946
• 关键词: Adult; Affect; Age; Aging; Animals; Beta Cell; CDKN1B gene; CDKN2A gene; Cell Cycle; Cell Cycle Progression; Cell Proliferation; Cells; Data; Diabetes Mellitus; Diet; Disease; Embryo; Endocrine; Failure; Fatty acid glycerol esters; Female; Future; Gene Expression; Gene Expression Profile; Gene Proteins; Gene Targeting; Genes; Genetic Transcription; Gestational Diabetes; Goals; Human; In Vitro; Incidence; Individual; Insulin; Insulin Resistance; Intervention; Islet Cell; Lead; Life; MAP Kinase Gene; Menin; Metabolic; Molecular; Molecular Target; Mus; Mutant Strains Mice; Neonatal; Nodal; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Pancreas; Pancreatic Injury; Pathway interactions; Placental Lactogen; Population; Pregnancy; Proliferating; Proteins; Regulation; Repression; Research; Role; Second Messenger Systems; Signal Pathway; Signal Transduction; Sorting - Cell Movement; Stimulus; Structure of beta Cell of islet; Testing; Tetanus Helper Peptide; Transgenes; Translating; Veterans; Weaning; age related; aged; blood glucose regulation; cdc Genes; diabetic; improved; in vivo; inhibitor/antagonist; islet; male; mutant; new therapeutic target; postnatal; pregnant; prevent; public health relevance; research study; response; response to injury; second messenger; transcription factor

DESCRIPTION (provided by applicant): The incidence of both Type 2 and gestational diabetes increase with age, due in part to a decline in b cell proliferation as individuals age. This may be due in part to the increased expression of cell cycle inhibitors in aged b cells, and a concomitant decrease in expression of cell cycle activators. However, insulin resistant states, such as obesity and pregnancy, normally stimulate replication in adult quiescent b cells. Failure to increase b cell mass in the face of insulin resistance can lead to Type 2 diabetes or gestational diabetes. The FoxM1 transcription factor is expressed in proliferating cells, regulates cell cycle genes, and promotes cell cycle progression. The Gannon lab discovered that mice lacking FoxM1 in their pancreas became diabetic due to a failure of b cell mass expansion after four weeks of age. We subsequently showed that FoxM1 is essential for b cell replication in response to all stimuli tested including pancreatic injury, pregnancy, and high fat diet. b cell proliferative stimuli were all found to induce Foxm1 gene expression in vivo. We hypothesize that FoxM1 represents a nodal point at which all stimulatory pathways for b cell proliferation intersect, and that FoxM1 gene expression and protein activity are enhanced by b cell proliferative stimuli. We predict that FoxM1 represent an excellent candidate for enhancement of replication in older b cells and thus may be a target for improving b cell mass expansion in diabetic individuals. These hypotheses will be tested using in vitro and in vivo approaches. In vitro, we will determine whether pharmacological activators of known b cell proliferative second messenger signaling pathways induce Foxm1 gene expression and/or protein activity in islets isolated from mice of different ages. In vivo, we will use microarray analyses to determine the effects of loss of FoxM1 on the b cell transcriptome under normal and stimulatory conditions. We will also examine whether FoxM1 mainly acts to promote b cell replication through its repression of cell cycle inhibitors. Finally, we will test whether expression of an activated form of FoxM1 in aged b cells is able to overcome the decline in replication that normally occurs with age. A thorough understanding of how FoxM1 functions to regulate b cell replication will lead to strategies for enhancing b cell proliferation and augmenting b cell mass for the treatment of diabetes, a disease that currently affects 16% of the veteran population and is expected in to increase even further in the coming years.

描述（由申请人提供）： 2型糖尿病和妊娠期糖尿病的发病率都随着年龄的增长而增加，部分原因是随着个体年龄的增长，B细胞增殖下降。这可能部分是由于细胞周期抑制剂在老化B细胞中的表达增加，以及伴随的细胞周期激活剂表达的减少。然而，胰岛素抵抗状态，如肥胖和怀孕，通常刺激成年静止B细胞的复制。在胰岛素抵抗的情况下，如果不能增加B细胞数量，可能会导致2型糖尿病或妊娠糖尿病。FoxM 1转录因子在增殖细胞中表达，调节细胞周期基因，并促进细胞周期进程。甘农实验室发现，胰腺中缺乏FoxM 1的小鼠在4周龄后由于B细胞群扩增失败而患上糖尿病。 我们随后发现，FoxM 1是必不可少的B细胞复制在所有测试的刺激，包括胰腺损伤，怀孕，和高脂肪饮食。发现B细胞增殖刺激物均诱导体内Foxm 1基因表达。我们假设FoxM 1代表了一个节点，所有B细胞增殖的刺激途径在此交叉，并且FoxM 1基因表达和蛋白活性通过B细胞增殖刺激而增强。我们预测，FoxM 1代表了一个很好的候选人，在老年B细胞的复制增强，因此可能是一个目标，以改善糖尿病患者的B细胞群扩增。 将使用体外和体内方法对这些假设进行检验。在体外，我们将确定是否已知的B细胞增殖的第二信使信号通路的药理学激活剂诱导Foxm 1基因表达和/或蛋白质的活性在胰岛分离自不同年龄的小鼠。在体内，我们将使用微阵列分析，以确定在正常和刺激条件下，FoxM 1的损失对B细胞转录组的影响。我们还将研究FoxM 1是否主要通过抑制细胞周期抑制剂来促进B细胞复制。最后，我们将测试是否在老化的B细胞中表达活化形式的FoxM 1能够克服通常随着年龄的增长而发生的复制下降。彻底了解FoxM 1如何调节B细胞复制，将导致提高B细胞增殖和增加B细胞质量治疗糖尿病的策略，糖尿病目前影响16%的退伍军人，预计在未来几年将进一步增加。